デフォルト表紙
市場調査レポート
商品コード
1206647

免疫療法薬市場:タイプ別、治療領域別、エンドユーザー別、地域別、2023-2028年

Immunotherapy Drugs Market by Type, Therapy Area, End User, and Region 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 143 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
免疫療法薬市場:タイプ別、治療領域別、エンドユーザー別、地域別、2023-2028年
出版日: 2023年01月31日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

免疫療法薬の世界市場規模は、2022年に1954億米ドルに達しました。今後、IMARCグループは、2023年から2028年の間に8.9%の成長率(CAGR)を示し、2028年までに3,278億米ドルに達すると予測しています。

免疫療法薬は、リンパ腫、メラノーマ、肉腫、肺がん、膀胱がん、腎臓がん、乳がんなどの治療に用いられる特殊な医薬品です。免疫系の特定の細胞を標的とし、エネルギーレベルを高める。また、身体の自然な防御機能を刺激し、アレルギーや細菌・ウイルスによる感染症に対抗するのを助けます。また、抗体の生成を助ける免疫学的反応を引き起こすことで、がん細胞の成長を防ぐこともできます。さらに、腫瘍やその他の慢性疾患の合併症を最小限に抑える効果があることから、免疫療法薬の需要は世界的に高まっています。

免疫療法薬の市場動向

  • 世界の老齢人口の増加や、がん、腫瘍、標的疾患の有病率の上昇は、市場にプラスの影響を与える主要な要因の一つです。また、多忙なスケジュールや様々な遺伝性疾患、生活習慣病の増加により、世界的に免疫療法薬の需要が高まっています。これとは別に、モノクローナル抗体やバイオシミラー医薬品の需要の高まりは、メーカーに有利な成長の機会を提供しています。また、がんの早期診断・早期治療に対する医療従事者の意識が高まっていることも、免疫療法薬の売上を増加させる要因となっています。さらに、主要な市場参加者が製品ポートフォリオを拡大し、競争力を得るために、戦略的提携や新製品の開発に注力するようになっていることも、市場の成長を後押ししています。さらに、病院、薬局、研究所の世界の拡大が、良好な市場見通しをもたらしています。さらに、大手製薬企業やバイオテクノロジー企業が、免疫療法薬の処方を強化するために研究開発(R&D)活動への投資を増やしていることも、市場の促進要因になると予想されます。

主な市場セグメンテーション

  • IMARC Groupは、免疫療法薬の世界市場レポートにおいて、2023年から2028年までの世界、地域、国レベルでの予測とともに、各サブセグメントにおける主要動向の分析を行っています。当レポートでは、市場をタイプ、治療分野、エンドユーザーに基づいて分類しています。

タイプ別の内訳

  • モノクローナル抗体
  • ワクチン
  • インターフェロンαおよびβ
  • インターロイキン

治療領域別内訳

  • がん
  • 自己免疫疾患・炎症性疾患
  • 感染症
  • その他

エンドユーザー別内訳

  • 病院
  • クリニック
  • その他

地域別の内訳

  • 北米
  • 米国
  • カナダ
  • アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
  • 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
  • ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
  • 中東とアフリカ

本レポートで回答した主な質問

  • 世界の免疫療法薬市場はこれまでどのように推移し、今後数年間はどのように推移するのか?
  • COVID-19は世界の免疫療法薬市場にどのような影響を与えたか?
  • 主要な地域別市場とは?
  • 市場のタイプ別区分は?
  • 治療領域別の市場内訳は?
  • エンドユーザー別の市場内訳は?
  • 業界のバリューチェーンにおける様々なステージとは?
  • 業界における主要な促進要因と課題は何か?
  • 世界の免疫療法薬の市場構造と主要プレイヤーは?
  • 業界における競合の度合いとは?

目次

第1章 序文

第2章 調査手法と範囲

  • 調査の目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要な産業動向

第5章 免疫療法薬の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 薬剤タイプ別市場内訳

  • モノクローナル抗体
    • 市場動向
    • 市場予測
  • ワクチン
    • 市場動向
    • 市場予測
  • インターフェロンα、β
    • 市場動向
    • 市場展望
  • インターロイキン
    • 市場動向
    • 市場展望

第7章 治療領域別市場内訳

  • がん領域
    • 市場動向
    • 市場予測
  • 自己免疫疾患・炎症性疾患
    • 市場動向
    • 市場予測
  • 感染症
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 エンドユーザー別市場内訳

  • 病院
    • 市場動向
    • 市場予測
  • 診療所
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場展望
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場展望
    • 日本
      • 市場動向
      • 市場展望
    • インド
      • 市場動向
      • 市場展望
    • 韓国市場
      • 市場動向
      • 市場展望
    • オーストラリア
      • 市場動向
      • 市場展望
    • インドネシア
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場展望
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場展望
    • スペイン
      • 市場動向
      • 市場展望
    • ロシア
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場展望
    • メキシコ
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場展望

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターズファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競争情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AstraZeneca plc
    • Bayer AG
    • Boehringer Ingelheim International GmbH
    • Bristol-Myers Squibb Company
    • F. Hoffmann-La Roche AG
    • GSK plc
    • Merck & Co. Inc.
    • Pfizer Inc.
    • Sanofi S.A.

本レポートに記載されている企業名は一部であり、全ての企業名は本レポートに記載されています。

図表

List of Figures

  • Figure 1: Global: Immunotherapy Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Immunotherapy Drugs Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Immunotherapy Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Immunotherapy Drugs Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Immunotherapy Drugs Market: Breakup by Therapy Area (in %), 2022
  • Figure 6: Global: Immunotherapy Drugs Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Immunotherapy Drugs Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Immunotherapy Drugs (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Immunotherapy Drugs (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Immunotherapy Drugs (Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Immunotherapy Drugs (Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Immunotherapy Drugs (Interferons Alpha and Beta) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Immunotherapy Drugs (Interferons Alpha and Beta) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Immunotherapy Drugs (Interleukins) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Immunotherapy Drugs (Interleukins) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Immunotherapy Drugs (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Immunotherapy Drugs (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Immunotherapy Drugs (Autoimmune and Inflammatory Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Immunotherapy Drugs (Autoimmune and Inflammatory Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Immunotherapy Drugs (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Immunotherapy Drugs (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Immunotherapy Drugs (Other Therapy Areas) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Immunotherapy Drugs (Other Therapy Areas) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Immunotherapy Drugs (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Immunotherapy Drugs (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Immunotherapy Drugs (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Immunotherapy Drugs (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Immunotherapy Drugs (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Immunotherapy Drugs (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: North America: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: North America: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: United States: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: United States: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Canada: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Canada: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Asia-Pacific: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Asia-Pacific: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: China: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: China: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Japan: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Japan: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: India: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: India: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: South Korea: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: South Korea: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Australia: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Australia: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Indonesia: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Indonesia: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Others: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Others: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Europe: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Europe: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Germany: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Germany: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: France: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: France: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: United Kingdom: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: United Kingdom: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Italy: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Italy: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Spain: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Spain: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Russia: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Russia: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Latin America: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Latin America: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Brazil: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Brazil: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Mexico: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Mexico: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Others: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Others: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Middle East and Africa: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Middle East and Africa: Immunotherapy Drugs Market: Breakup by Country (in %), 2022
  • Figure 78: Middle East and Africa: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Global: Immunotherapy Drugs Industry: SWOT Analysis
  • Figure 80: Global: Immunotherapy Drugs Industry: Value Chain Analysis
  • Figure 81: Global: Immunotherapy Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Immunotherapy Drugs Market: Key Industry Highlights, 2022 & 2028
  • Table 2: Global: Immunotherapy Drugs Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Immunotherapy Drugs Market Forecast: Breakup by Therapy Area (in Million US$), 2023-2028
  • Table 4: Global: Immunotherapy Drugs Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Immunotherapy Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Immunotherapy Drugs Market: Competitive Structure
  • Table 7: Global: Immunotherapy Drugs Market: Key Players
目次
Product Code: SR1323A119_Report

The global immunotherapy drugs market size reached US$ 195.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 327.8 Billion by 2028, exhibiting a growth rate (CAGR) of 8.9% during 2023-2028.

Immunotherapy drugs are specialized medications used for treating lymphoma, melanoma, sarcoma, and lung, bladder, kidney, and breast cancer. They target specific cells of the immune system and boost energy levels. They stimulate the natural defenses of the body and help fight against allergies and infections caused by bacteria and viruses. They also aid in preventing the growth of cancer cells by triggering an immunological response that aids in generating antibodies. Moreover, as they are effective in minimizing the complications of tumors and other chronic disorders, the demand for immunotherapy drugs is rising across the globe.

Immunotherapy Drugs Market Trends:

  • The growing global geriatric population and the rising prevalence of cancer, tumor, and target diseases worldwide represent one of the key factors positively influencing the market. In addition, hectic schedules and the increasing occurrence of various genetic and lifestyle diseases are catalyzing the demand for immunotherapy drugs across the globe. Apart from this, the escalating demand for monoclonal antibodies and biosimilar drugs is offering lucrative growth opportunities to manufacturers. This, in confluence with the rising awareness among individuals and healthcare professionals about the benefits of early diagnosis and treatment of cancer, is increasing the overall sales of immunotherapy drugs. Furthermore, the increasing focus of key market players on strategic collaborations and new product developments to expand their product portfolio and gain a competitive edge is propelling the market growth. Additionally, the expansion of hospitals, pharmacies, and research laboratories across the globe is offering a favorable market outlook. Moreover, increasing investments by leading pharmaceutical and biotechnology companies in research and development (R&D) activities to enhance the formulation of immunotherapy drugs are expected to drive the market.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global immunotherapy drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, therapy area and end user.

Breakup by Type:

  • Monoclonal Antibodies
  • Vaccines
  • Interferons Alpha and Beta
  • Interleukins

Breakup by Therapy Area:

  • Cancer
  • Autoimmune and Inflammatory Diseases
  • Infectious Diseases
  • Others

Breakup by End User:

  • Hospitals
  • Clinics
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GSK plc, Merck & Co. Inc., Pfizer Inc. and Sanofi S.A. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global immunotherapy drugs market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global immunotherapy drugs market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the therapy area?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global immunotherapy drugs market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Immunotherapy Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Type

  • 6.1 Monoclonal Antibodies
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Vaccines
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Interferons Alpha and Beta
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Interleukins
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Therapy Area

  • 7.1 Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Autoimmune and Inflammatory Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Infectious Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AstraZeneca plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bayer AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Boehringer Ingelheim International GmbH
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Bristol-Myers Squibb Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 F. Hoffmann-La Roche AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 GSK plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Merck & Co. Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sanofi S.A.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report